Fibralign and MedTech Innovator Featured in General Surgery News
The prizes valued at $150,000 awarded to the company that won the 2014 MedTech Innovator competition were nothing to sneeze at; but just as important, if not more so, were the support and exposure the startup received as participants of MTI’s accelerator program.
“It meant a lot to us to get so much attention for what we do,” said Greg King, CEO of Fibralign Corporation, a developer of biomedical devices. “It definitely gave our team a boost by affirming that we were working on something really important.”
